Canada Clinical Nutrition Market, by Nutrition Type (Enteral Nutrition {Standard Nutrition and Disease Specific Nutrition} and Parenteral Nutrition {Amino Acid, Carbohydrates, Vitamins and Minerals and Others (Proteins, Lipids among Others)}), by Form (Powder, Liquid, Tablets, Capsules, Gummies and Others {Nutrition Bar, among Others}), by Route of Administration (Oral, Enteral and Parenteral), by Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), by Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases and Others {Cardiovascular Diseases and Others}, by End User (Hospitals, Ambulatory Surgical Centers and Long Term Care Facilities) is estimated to be valued at US$ 642.9 Million in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Key market players are focusing on signing distribution agreements with distributors in order to increase their customer base. This is expected to drive the growth of the Canada clinical nutrition market over the forecast period. For instance, in March 2021, Mead Johnson & Company, LLC, manufacturer of infant formula, entered into an exclusive distribution agreement with Abbott Laboratories, an American multinational medical devices to distribute their branded pediatric and adult clinical nutrition products in Canada. This partnership boosted Mead Johnson's product offerings and outreach in hospital and clinical settings significantly.
Canada Clinical Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic is expected to have a positive effect on the Canada clinical nutrition market due to a significant increase in the number of geriatric population in Canada and the increasing requirement of clinical nutrition for their well being. The growing geriatric population in Canada is leading to higher instances of age-related illnesses requiring critical care. This is stimulating demand for high-protein and nutrient-dense enteral formulas used in hospitals. Similarly, with obesity becoming more prevalent, metabolic syndrome diagnoses are also on the rise. Clinical nutrition products enriched with antioxidants, fiber, and low-glycemic-load ingredients catering to metabolic disorder patients are finding many new patients. The wide availability of specialized clinical nutrition solutions tailored to the specific nutritional needs of these growing patient segments is expected to substantially contribute to the Canada Clinical nutrition market expansion over the coming years.
Canada Clinical Nutrition Market: Key Developments
In March 2022, Danone S.A., a French multinational food-products corporation, launched a new line of specialized medical nutrition drinks targeted at seniors and older patients. The line, called Ensure Vitality, contains 30 grams of high-quality protein per serving to help support muscle health.
In March 2022, the Abbott, a global healthcare company launched a new high-protein nutrition product called Ensure Max Protein. The new product contains 30 grams of protein per serving to help support muscle strength and overall health.
Browse 18 Market Data Tables and 37 Figures spread through 201 Pages and in-depth TOC on “Canada Clinical Nutrition Market”- Forecast to 2030, Canada Clinical Nutrition Market, by Nutrition Type (Enteral Nutrition {Standard Nutrition and Disease Specific Nutrition} and Parenteral Nutrition {Amino Acid, Carbohydrates, Vitamins and Minerals and Others (Proteins, Lipids among Others)}), by Form (Powder, Liquid, Tablets, Capsules, Gummies and Others {Nutrition Bar, among Others}), by Route of Administration (Oral, Enteral and Parenteral), by Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), by Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases and Others {Cardiovascular Diseases and Others}, by End User (Hospitals, Ambulatory Surgical Centers and Long Term Care Facilities)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/canada-clinical-nutrition-market-4446
Key Takeaways of the Canada Clinical Nutrition Market:
- The Canada clinical nutrition market is expected to exhibit a CAGR of 5.4% during the forecast period. The acquisition of nutrition-based companies in the emerging economies offers lucrative growth opportunities for players in the Canada clinical nutrition market.
- Among nutrition type, enteral nutrition is the dominating segment. Increasing adoption of inorganic growth strategies ,such as acquisition by market players for providing personalized nutrition to the customers is expected to boost the segment growth over the forecast period. For instance, in December 2021, Danone announced the acquisition of Major Pharmaceuticals, a leading provider of tube feeding and oral nutritional supplements in Canada. This US$ 125 million acquisition expanded Danone's portfolio of clinical and medical nutrition products in the important Canadian market.
- Major players operating in the Canada clinical nutrition market are Nestle S.A., Abbott Laboratories, Mead Johnson Nutrition Company, Danone S.A., Bayer AG, Fresenius Kabi AG, Baxter International Inc., Cambrooke Therapeutics, Vicore Pharma Holding AB, Ajinomoto Cambrooke, Inc., Nutricia North America, Vicore Pharma Holding AB, Schatten Medical, Otsuka Pharmaceutical and Vitaflo Asia-Pacific
